Results 1 to 10 of about 3,874 (114)
Journal of Experimental Medicine, 1962 Injection of a small bacteriophage ϕX 174 into guinea pigs results in an accelerated elimination of phage detectable as early as 24 hours after injection. The immune nature of the accelerated elimination is indicated by its specificity, by the appearance of excess specific serum antibody after phage elimination, and by the prevention of accelerated ...
J W Uhr
exaly +3 more sources
Journal of Experimental Medicine, 1961 The suppression of antibody formation by passively administered antibody is influenced by the dose and nature of the antigen, type of immunization procedure, ratio of antibody to antigen, species origin and characteristics of the antiserum used, as well as the species selected for immunization.
J W Uhr
exaly +5 more sources
ANTIBODY FORMATION IN VITRO [PDF]
Journal of Experimental Medicine, 1961 Neutralizing activity against T2 bacteriophage appeared in cultures of lymph node cells from normal rats in response to their in vitro stimulation with a cell-free filtrate derived from homogenized rat macrophages which had been incubated with T2 bacteriophage. This activity was specifically directed against T2 bacteriophage.
exaly +3 more sources
Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19 [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims Data comparing the antibody responses of different coronavirus disease 2019 (COVID-19) vaccine platforms according to dose with natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced antibody responses are ...
Hye Hee Cha +6 more
doaj +1 more source
Anti-SARS-CoV-2 antibody responses in convalescent plasma donors with varying severity of COVID-19 illness [PDF]
Vojnosanitetski Pregled, 2022 Background/Aim. Plasma containing a high titer of anti-SARS-CoV-2 antibodies, donated from individuals who recovered from COVID-19, has the potential to be used as initial therapy for patients who have been infected (passive immunization).
Grujić Jasmina +4 more
doaj +1 more source
Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19 [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims The rapidity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory B or T cell response in vaccinated individuals is important for our understanding of immunopathogenesis of coronavirus disease 2019 (COVID-19 ...
Ji Yeun Kim +5 more
doaj +1 more source
Humoral response to viral vector COVID-19 vaccine in hemodialysis patients [PDF]
Kidney Research and Clinical Practice, 2022 Background The coronavirus disease 2019 (COVID-19) vaccine is not readily available in many countries where dosing interval is spaced more than ideal. Patients with chronic kidney disease, especially those on maintenance hemodialysis, have a tendency for
Niranjan Raja +5 more
doaj +1 more source
Therapies for Chronic Allograft Rejection
Frontiers in Pharmacology, 2021 Remarkable advances have been made in the pathophysiology, diagnosis, and treatment of antibody-mediated rejection (ABMR) over the past decades, leading to improved graft outcomes.
Min Young Kim, Daniel C. Brennan
doaj +1 more source
Frontiers in Immunology, 2021 Predicted Indirectly ReCognizable Human Leukocyte Antigen (HLA) Epitopes (PIRCHE) are known to be a significant risk factor for the development of donor HLA-specific antibodies after organ transplantation.
Matthias Niemann +8 more
doaj +1 more source
The Journal of Experimental Medicine, 1963 Injection of a sufficient dose of bacteriophage ϕX 174 into guinea pigs results in the formation of rapidly sedimenting antibody molecules (19S), and later, slowly sedimenting molecules (7S). Above a threshold dose of antigen, the relative rate of 19S formation is maximal and dose-independent; below this dose, slower relative rates are obtained.
J W, UHR, M S, FINKELSTEIN
openaire +2 more sources